Watchlist Price Alert

Sigilon Therapeutics Inc. (SGTX)

NASDAQ: SGTX · Real-Time Price · USD

22.47

-0.59 (-2.56%)

At close: Aug 10, 2023, 8:00 PM

undefined

undefined%

After-hours: undefined

Sigilon Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q4 2019
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Dec 31, 2019
Cash & Equivalents	19.62M	41.26M	42.07M	32.92M	34.55M	64.49M	107.14M	140.39M	162.41M	178.79M	202.23M	62.64M	76.07M
Short-Term Investments	15.28M	15.11M	27.56M	45.34M	53.66M	38.62M	16.21M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.04M	1.04M	1.03M	1.03M	1.03M	1.12M	1.12M	1.29M	1.29M	1.12M	1.12M	2.2M	641K
Receivables	6.86M	4.96M	3.46M	23K	23K	62K	59K	27K	178K	140K	177K	67K	136K
Inventory	250K	251K	250K	n/a	n/a	250K	250K	75K	75K	75K	75K	75K	n/a
Other Current Assets	2.86M	3.07M	1.08M	2.33M	3.94M	6.23M	2.73M	3.53M	3.61M	4.06M	1.73M	916K	732K
Total Current Assets	44.87M	64.65M	74.41M	80.63M	92.17M	109.65M	126.39M	144.03M	166.27M	183.06M	204.21M	63.7M	76.94M
Property-Plant & Equipment	9.65M	10.9M	11.83M	12.96M	14.22M	15.4M	16.86M	18.48M	18.56M	19.2M	19.72M	11.55M	12.8M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	10.69M	11.94M	12.87M	13.99M	15.25M	16.52M	17.98M	19.77M	19.85M	20.32M	20.84M	13.75M	13.44M
Total Assets	55.56M	76.59M	87.28M	94.62M	107.42M	126.17M	144.37M	163.8M	186.12M	203.38M	225.05M	77.45M	90.38M
Account Payables	1.11M	1.33M	936K	1.41M	1.05M	2.04M	2.34M	3.23M	4.66M	2.01M	1.99M	671K	2M
Deferred Revenue	13.78M	12.99M	12.88M	12.07M	16.32M	19.21M	17.03M	24.31M	25.96M	20.13M	31.78M	31.72M	29.14M
Short-Term Debt	4.52M	11.16M	11.15M	11.13M	9.44M	7.74M	6.51M	5.67M	5.08M	5.43M	5.36M	3.29M	3.38M
Other Current Liabilities	5.83M	3.51M	6.02M	5.95M	6.5M	8.06M	9M	7.66M	8.69M	6.91M	7.89M	9.64M	5.85M
Total Current Liabilities	25.25M	28.99M	30.99M	30.55M	33.32M	37.05M	34.89M	40.87M	44.39M	34.48M	47.02M	45.33M	40.38M
Long-Term Debt	2.87M	14.3M	16.91M	19.48M	22.01M	24.53M	26.99M	29.45M	30.22M	30.97M	31.7M	25.55M	21.68M
Other Long-Term Liabilities	n/a	n/a	233K	176K	281K	n/a	n/a	176K	176K	176K	176K	233K	90.54M
Total Long-Term Liabilities	2.87M	14.3M	17.14M	19.65M	22.29M	24.53M	32.32M	29.63M	30.67M	39.87M	31.88M	29.45M	127.77M
Total Liabilities	28.11M	43.29M	48.14M	50.21M	55.61M	61.58M	67.21M	70.49M	75.05M	74.35M	78.89M	74.78M	168.14M
Total Debt	7.39M	25.47M	28.06M	30.61M	31.45M	32.27M	33.5M	35.12M	35.3M	36.4M	37.06M	28.85M	25.05M
Common Stock	3K	32K	32K	32K	32K	32K	32K	32K	32K	32K	31K	21K	5K
Retained Earnings	-271.68M	-264.18M	-256.8M	-250.12M	-241.44M	-227.1M	-213.24M	-195.49M	-175.34M	-154.9M	-135.93M	-120.74M	-81.32M
Comprehensive Income	-177K	-273K	-429K	-636K	-556K	-389K	-10K	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	27.45M	33.29M	39.14M	44.41M	51.81M	64.59M	77.16M	93.3M	111.07M	129.03M	146.16M	2.67M	-77.76M
Total Investments	15.28M	15.11M	27.56M	45.34M	53.66M	38.62M	16.21M	n/a	n/a	n/a	n/a	n/a	n/a